Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 8-K call announcement, 10-Q stay in one workspace.
VRDN
$18.18
-0.55%
VRDN
· Viridian Therapeutics, Inc.\DE
$18.18
-0.10 (-0.55%)
At close · Oct 8
Return incl. dividend (before tax)
Market Cap
$2.07B
Shares
113.29M
Volume · Oct 8
1.08M
Avg daily vol (3M)
1.71M
All webcasts
Earnings call · FY2026 Q1
Viridian Therapeutics, Inc.\DE (VRDN) Q1 2026 Earnings Call
Research coverage
3 live sources
Open each available source without leaving this research workspace.
Revenue
$141,000
+95.8% YoY
Net income
-$104.90M
Research materials
Open the source you need; every reader stays inside this workspace.
Quarter detail
How the reported period landed and where the business moved.
SEC filing · Item 2.02
8-K earnings release
Filed May 5, 2026 · complete as-filed document
SEC periodic report
10-Q report
Filed May 5, 2026 · complete as-filed document
SEC call announcement
8-K call announcement
Filed May 5, 2026 · complete as-filed document